drugset / Trial / NCT00154037
Investigation of Vascular Relaxing Effects of Candesartan and Pioglitazone.
RandomizedParallel-groupDouble-blindTreatment
Summary
The study is designed to test the hypothesis in healthy subjects that candesartan and pioglitazone provide additional vascular relaxing or modulating effects in addition to their blood-pressure and blood glucose level reducing ability, respectively.
Timeline
- Start
- 2005-10
- Primary completion
- —
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Candesartan | Unknown | 16 mg | Oral |
| Subject | Pioglitazone | Small molecule | 45 mg | Oral |
Indications
No indication recorded.